Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant AAV vectors provides neuroprotection and induces behavioural recovery in a primate model of Parkinson's disease

Eslamboli, A., Georgievska, B., Ridley, R. M., Baker, H. F., Muzyczka, N., Burger, C., Mandel, R. J., Annett, L.E. and Kirik, D. (2005) Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant AAV vectors provides neuroprotection and induces behavioural recovery in a primate model of Parkinson's disease. pp. 769-777. ISSN 0270-6474
Copy

picture_as_pdf
102994.pdf
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):